نتائج البحث 481-490 من 23912 لعملية البحث عن B cell lymphomas
... B-cell lymphoma 2 (BCL2) inhibitor. Optical Fusion Trans-Perineal Grid. Rochester, Minn. The purpose of this study is to evaluate and assess a new perineal ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Aggressive Malignancy PDX (Avatar) and ...
... cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...
Axicabtagene Ciloleucel Versus Standard Of Care Therapy As First-Line Therapy In High-Risk Large B-Cell Lymphoma. Eau Claire, Wis., La Crosse, Wis., Mankato ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas ... B Cell Lymphoma (DLBCL), Hodgkin Lymphoma (HL) and Post-transplant ...
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...
... B-cell lymphoma 2 (BCL2) inhibitor. Aggressive Malignancy PDX (Avatar) and Cryopreservation Program. Rochester, Minn. The purpose of this study is to assess ...
Axicabtagene Ciloleucel Versus Standard Of Care Therapy As First-Line Therapy In High-Risk Large B-Cell Lymphoma ... B Acute Lymphoblastic Leukemia.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.